Nrf2 targeting by sulforaphane: A potential therapy for cancer treatment

References

• Abbas, A., Hall, J. A., Patterson, W. L., 3rd, Ho, E., Hsu, A., Al-Mulla, F. and Georgel, P. T. (2016). Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines. Biochem. Cell Biol. 94:71–81.
   PubMed Web of Science ®Google Scholar
• Alumkal, J. J., Slottke, R., Schwartzman, J., Cherala, G., Munar, M., Graff, J. N., Beer, T. M., Ryan, C. W., Koop, D. R., Gibbs, A., Gao, L., Flamiatos, J. F., Tucker, E., Kleinschmidt, R. and Mori, M. (2015). A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer. Invest. New Drugs 33:480–489.
   PubMed Web of Science ®Google Scholar
• Angelino, D. and Jeffery, E. (2014). Glucosinolate hydrolysis and bioavailability of resulting isothiocyanates: focus on glucoraphanin. J. Funct. Foods 7:67–76.
   Web of Science ®Google Scholar
• Ares, A. M., Valverde, S., Bernal, J. L., Nozal, M. J., and Bernal, J. (2015). Development and validation of a LC–MS/MS method to determine sulforaphane in honey. Food Chem. 181:263–269.
   PubMed Web of Science ®Google Scholar
• Asakage, M., Tsuno, N. H., Kitayama, J., Tsuchiya, T., Yoneyama, S., Yamada, J., Okaji, Y., Kaisaki, S., Osada, T., Takahashi, K. and Nagawa, H. (2006). Sulforaphane induces inhibition of human umbilical vein endothelial cells proliferation by apoptosis. Angiogenesis 9:83–91.
   PubMedGoogle Scholar
• Atwell, L. L., Hsu, A., Wong, C. P., Stevens, J. F., Bella, D., Yu, T. W., Pereira, C. B., Löhr, C. V., Christensen, J. M. and Dashwood, R. H. (2015). Absorption and chemopreventive targets of sulforaphane in humans following consumption of broccoli sprouts or a myrosinase‐treated broccoli sprout extract. Mol. Nutr. Food Res. 59:424–433.
   PubMed Web of Science ®Google Scholar
• Atwell, L. L., Zhang, Z., Mori, M., Farris, P. E., Vetto, J. T., Naik, A. M., Oh, K. Y., Thuillier, P., Ho, E. and Shannon, J. (2015). Sulforaphane bioavailability and chemopreventive activity in women scheduled for breast biopsy. Cancer Prev. Res. (Phila) 8:1184–1191.
   PubMed Web of Science ®Google Scholar
• Bacon, J. R., Williamson, G., Garner, R. C., Lappin, G., Langouet, S. and Bao, Y. (2003). Sulforaphane and quercetin modulate PhIP-DNA adduct formation in human HepG2 cells and hepatocytes. Carcinogenesis 24:1903–1911.
   PubMed Web of Science ®Google Scholar
• Bergantin, E., Quarta, C., Nanni, C., Fanti, S., Pession, A., Cantelli-Forti, G., Tonelli, R. and Hrelia, P. (2014). Sulforaphane induces apoptosis in rhabdomyosarcoma and restores TRAIL-sensitivity in the aggressive alveolar subtype leading to tumor elimination in mice. Cancer Biol. Ther. 15:1219–1225.
   PubMed Web of Science ®Google Scholar
• Bertl, E., Bartsch, H. and Gerhauser, C. (2006). Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention. Mol. Cancer Ther. 5:575–585.
   PubMed Web of Science ®Google Scholar
• Block, G., Patterson, B. and Subar, A. (1992). Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer 18:1–29.
   PubMed Web of Science ®Google Scholar
• Block, K. I., Gyllenhaal, C., Lowe, L., Amedei, A., Amin, A. R., Amin, A., Aquilano, K., Arbiser, J., Arreola, A., Arzumanyan, A., Ashraf, S. S., Azmi, A. S., Benencia, F., Bhakta, D., Bilsland, A., Bishayee, A., Blain, S. W., Block, P. B., Boosani, C. S., Carey, T. E., Carnero, A., Carotenuto, M., Casey, S. C., Chakrabarti, M., Chaturvedi, R., Chen, G. Z., Chen, H., Chen, S., Chen, Y. C., Choi, B. K., Ciriolo, M. R., Coley, H. M., Collins, A. R., Connell, M., Crawford, S., Curran, C. S., Dabrosin, C., Damia, G., Dasgupta, S., DeBerardinis, R. J., Decker, W. K., Dhawan, P., Diehl, A. M., Dong, J. T., Dou, Q. P., Drew, J. E., Elkord, E., El-Rayes, B., Feitelson, M. A., Felsher, D. W., Ferguson, L. R., Fimognari, C., Firestone, G. L., Frezza, C., Fujii, H., Fuster, M. M., Generali, D., Georgakilas, A. G., Gieseler, F., Gilbertson, M., Green, M. F., Grue, B., Guha, G., Halicka, D., Helferich, W. G., Heneberg, P., Hentosh, P., Hirschey, M. D., Hofseth, L. J., Holcombe, R. F., Honoki, K., Hsu, H. Y., Huang, G. S., Jensen, L. D., Jiang, W. G., Jones, L. W., Karpowicz, P. A., Keith, W. N., Kerkar, S. P., Khan, G. N., Khatami, M., Ko, Y. H., Kucuk, O., Kulathinal, R. J., Kumar, N. B., Kwon, B. S., Le, A., Lea, M. A., Lee, H. Y., Lichtor, T., Lin, L. T., Locasale, J. W., Lokeshwar, B. L., Longo, V. D., Lyssiotis, C. A., MacKenzie, K. L., Malhotra, M., Marino, M., Martinez-Chantar, M. L., Matheu, A., Maxwell, C., McDonnell, E., Meeker, A. K., Mehrmohamadi, M., Mehta, K., Michelotti, G. A., Mohammad, R. M., Mohammed, S. I., Morre, D. J., Muralidhar, V., Muqbil, I., Murphy, M. P., Nagaraju, G. P., Nahta, R., Niccolai, E., Nowsheen, S., Panis, C., Pantano, F., Parslow, V. R., Pawelec, G., Pedersen, P. L., Poore, B., Poudyal, D., Prakash, S., Prince, M., Raffaghello, L., Rathmell, J. C., Rathmell, W. K., Ray, S. K., Reichrath, J., Rezazadeh, S., Ribatti, D., Ricciardiello, L., Robey, R. B., Rodier, F., Rupasinghe, H. P., Russo, G. L., Ryan, E. P., Samadi, A. K., Sanchez-Garcia, I., Sanders, A. J., Santini, D., Sarkar, M., Sasada, T., Saxena, N. K., Shackelford, R. E., Shantha Kumara, H. M., Sharma, D., Shin, D. M., Sidransky, D., Siegelin, M. D., Signori, E., Singh, N., Sivanand, S., Sliva, D., Smythe, C., Spagnuolo, C., Stafforini, D. M., Stagg, J., Subbarayan, P. R., Sundin, T., Talib, W. H., Thompson, S. K., Tran, P. T., Ungefroren, H., Vander Heiden, M. G., Venkateswaran, V., Vinay, D. S., Vlachostergios, P. J., Wang, Z., Wellen, K. E., Whelan, R. L., Yang, E. S., Yang, H., Yang, X., Yaswen, P., Yedjou, C., Yin, X., Zhu, J. and Zollo, M. (2015). Designing a broad-spectrum integrative approach for cancer prevention and treatment. Semin. Cancer Biol. 35Suppl:S276–S304.
   PubMed Web of Science ®Google Scholar
• Budnowski, J., Hanschen, F. S., Lehmann, C., Haack, M., Brigelius-Flohé, R., Kroh, L. W., Blaut, M., Rohn, S. and Hanske, L. (2013). A derivatization method for the simultaneous detection of glucosinolates and isothiocyanates in biological samples. Anal. Biochem. 441:199–207.
   PubMed Web of Science ®Google Scholar
• Cabello-Hurtado, F., Gicquel, M. and Esnault, M.-A. (2012). Evaluation of the antioxidant potential of cauliflower (Brassica oleracea) from a glucosinolate content perspective. Food Chem. 132:1003–1009.
   Web of Science ®Google Scholar
• Chang, C. C., Hung, C. M., Yang, Y. R., Lee, M. J. and Hsu, Y. C. (2013). Sulforaphane induced cell cycle arrest in the G2/M phase via the blockade of cyclin B1/CDC2 in human ovarian cancer cells. J. Ovarian Res. 6:41.
   PubMed Web of Science ®Google Scholar
• Chartoumpekis, D. V., Wakabayashi, N. and Kensler, T. W. (2015). Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism. Biochem. Soc. Trans. 43:639–644.
   PubMed Web of Science ®Google Scholar
• Chorley, B. N., Campbell, M. R., Wang, X., Karaca, M., Sambandan, D., Bangura, F., Xue, P., Pi, J., Kleeberger, S. R. and Bell, D. A. (2012). Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha. Nucleic Acids Res. 40:7416–7429.
   PubMed Web of Science ®Google Scholar
• Clarke, J. D., Dashwood, R. H. and Ho, E. (2008). Multi-targeted prevention of cancer by sulforaphane. Cancer Lett. 269:291–304.
   PubMed Web of Science ®Google Scholar
• Clarke, J. D., Hsu, A., Yu, Z., Dashwood, R. H. and Ho, E. (2011). Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells. Mol. Nutr. Food Res. 55:999–1009.
   PubMed Web of Science ®Google Scholar
• Conzatti, A., Fróes, F., Schweigert Perry, I. D. and Souza, C. (2014). Clinical and molecular evidence of the consumption of broccoli, glucoraphanin and sulforaphane in humans. Nutr. Hosp. 31:559–569.
   PubMed Web of Science ®Google Scholar
• Cornblatt, B. S., Ye, L., Dinkova-Kostova, A. T., Erb, M., Fahey, J. W., Singh, N. K., Chen, M. S., Stierer, T., Garrett-Mayer, E., Argani, P., Davidson, N. E., Talalay, P., Kensler, T. W. and Visvanathan, K. (2007). Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis 28:1485–1490.
   PubMed Web of Science ®Google Scholar
• Cornelis, M. C., El-Sohemy, A. and Campos, H. (2007). GSTT1 genotype modifies the association between cruciferous vegetable intake and the risk of myocardial infarction. Am. J. Clin. Nutr. 86:752–758.
   PubMed Web of Science ®Google Scholar
• Danilov, C. A., Chandrasekaran, K., Racz, J., Soane, L., Zielke, C. and Fiskum, G. (2009). Sulforaphane protects astrocytes against oxidative stress and delayed death caused by oxygen and glucose deprivation. Glia 57:645–656.
   PubMed Web of Science ®Google Scholar
• Davis, R., Singh, K. P., Kurzrock, R. and Shankar, S. (2009). Sulforaphane inhibits angiogenesis through activation of FOXO transcription factors. Oncol. Rep. 22:1473–1478.
   PubMed Web of Science ®Google Scholar
• De Nicola, G. R., Rollin, P., Mazzon, E. and Iori, R. (2014). Novel gram-scale production of enantiopure R-sulforaphane from Tuscan black kale seeds. Molecules 19:6975–6986.
   PubMed Web of Science ®Google Scholar
• DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., Scrimieri, F., Winter, J. M., Hruban, R. H., Iacobuzio-Donahue, C., Kern, S. E., Blair, I. A. and Tuveson, D. A. (2011). Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475:106–109.
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M. and Talalay, P. (2002). Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci U S A 99:11908–11913.
   PubMed Web of Science ®Google Scholar
• Dodson, M., Redmann, M., Rajasekaran, N. S., Darley-Usmar, V. and Zhang, J. (2015). KEAP1-NRF2 signalling and autophagy in protection against oxidative and reductive proteotoxicity. Biochem. J. 469:347–355.
   PubMed Web of Science ®Google Scholar
• Egner, P. A., Chen, J. G., Wang, J. B., Wu, Y., Sun, Y., Lu, J. H., Zhu, J., Zhang, Y. H., Chen, Y. S. and Friesen, M. D. (2011). Bioavailability of sulforaphane from two broccoli sprout beverages: results of a short-term, cross-over clinical trial in Qidong, China. Cancer Prev. Res. 4:384–395.
   PubMed Web of Science ®Google Scholar
• Egner, P. A., Chen, J. G., Wang, J. B., Wu, Y., Sun, Y., Lu, J. H., Zhu, J., Zhang, Y. H., Chen, Y. S., Friesen, M. D., Jacobson, L. P., Munoz, A., Ng, D., Qian, G. S., Zhu, Y. R., Chen, T. Y., Botting, N. P., Zhang, Q., Fahey, J. W., Talalay, P., Groopman, J. D. and Kensler, T. W. (2011). Bioavailability of Sulforaphane from two broccoli sprout beverages: results of a short-term, cross-over clinical trial in Qidong, China. Cancer Prev. Res. 4:384–395.
   PubMed Web of Science ®Google Scholar
• Facchini, A., Stanic, I., Cetrullo, S., Borzì, R. M., Filardo, G. and Flamigni, F. (2011). Sulforaphane protects human chondrocytes against cell death induced by various stimuli. J. Cell. Physiol. 226:1771–1779.
   PubMed Web of Science ®Google Scholar
• Fahey, J. W., Stephenson, K. K., Dinkova-Kostova, A. T., Egner, P. A., Kensler, T. W. and Talalay, P. (2005). Chlorophyll, chlorophyllin and related tetrapyrroles are significant inducers of mammalian phase 2 cytoprotective genes. Carcinogenesis 26:1247–1255.
   PubMed Web of Science ®Google Scholar
• Fahey, J. W., Zhang, Y. and Talalay, P. (1997). Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc. Natl. Acad. Sci. U. S. A. 94:10367–10372.
   PubMed Web of Science ®Google Scholar
• Feskanich, D., Ziegler, R. G., Michaud, D. S., Giovannucci, E. L., Speizer, F. E., Willett, W. C. and Colditz, G. A. (2000). Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J. Natl. Cancer Inst. 92:1812–1823.
   PubMed Web of Science ®Google Scholar
• Fimognari, C., Turrini, E., Sestili, P., Calcabrini, C., Carulli, G., Fontanelli, G., Rousseau, M., Cantelli-Forti, G. and Hrelia, P. (2014). Antileukemic activity of sulforaphane in primary blasts from patients affected by myelo- and lympho-proliferative disorders and in hypoxic conditions. PLoS One 9:e101991.
   PubMed Web of Science ®Google Scholar
• Ganin, H., Rayo, J., Amara, N., Levy, N., Krief, P. and Meijler, M. M. (2013). Sulforaphane and erucin, natural isothiocyanates from broccoli, inhibit bacterial quorum sensing. Medchemcomm 4:175–179.
   Web of Science ®Google Scholar
• Gross-Steinmeyer, K., Stapleton, P. L., Tracy, J. H., Bammler, T. K., Strom, S. C. and Eaton, D. L. (2010). Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expression. Toxicol. Sci. 116:422–432.
   PubMed Web of Science ®Google Scholar
• Han, D. and Row, K. H. (2011). Separation and purification of sulforaphane from broccoli by solid phase extraction. Int. J. Mol. Sci. 12:1854–1861.
   PubMed Web of Science ®Google Scholar
• Hanada, N., Takahata, T., Zhou, Q., Ye, X., Sun, R., Itoh, J., Ishiguro, A., Kijima, H., Mimura, J., Itoh, K., Fukuda, S. and Saijo, Y. (2012). Methylation of the KEAP1 gene promoter region in human colorectal cancer. BMC Cancer 12:66.
   PubMed Web of Science ®Google Scholar
• Hanahan, D. and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144:646–674.
   PubMed Web of Science ®Google Scholar
• Hayes, J. D. and Dinkova-Kostova, A. T. (2014). The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem. Sci. 39:199–218.
   PubMed Web of Science ®Google Scholar
• Hong, F., Freeman, M. L. and Liebler, D. C. (2005). Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane. Chem. Res. Toxicol. 18:1917–1926.
   PubMed Web of Science ®Google Scholar
• Houghton, C. A., Fassett, R. G. and Coombes, J. S. (2016). Sulforaphane and other nutrigenomic Nrf2 activators: Can the clinician's expectation be matched by the reality?. Oxid. Med. Cell. Longev. 2016:17.
   Web of Science ®Google Scholar
• Hsu, Y. C., Chang, S. J., Wang, M. Y., Chen, Y. L. and Huang, T. Y. (2013). Growth inhibition and apoptosis of neuroblastoma cells through ROS-independent MEK/ERK activation by sulforaphane. Cell Biochem. Biophys. 66:765–774.
   PubMed Web of Science ®Google Scholar
• Huang, Y., Li, W., Su, Z. Y. and Kong, A. N. (2015). The complexity of the Nrf2 pathway: beyond the antioxidant response. J. Nutr. Biochem. 26:1401–1413.
   PubMed Web of Science ®Google Scholar
• Jackson, S. J., Singletary, K. W. and Venema, R. C. (2007). Sulforaphane suppresses angiogenesis and disrupts endothelial mitotic progression and microtubule polymerization. Vascul. Pharmacol. 46:77–84.
   PubMed Web of Science ®Google Scholar
• Jee, H. G., Lee, K. E., Kim, J. B., Shin, H. K. and Youn, Y. K. (2011). Sulforaphane inhibits oral carcinoma cell migration and invasion in vitro. Phytother. Res. 25:1623–1628.
   PubMed Web of Science ®Google Scholar
• Jo, G. H., Kim, G. Y., Kim, W. J., Park, K. Y. and Choi, Y. H. (2014). Sulforaphane induces apoptosis in T24 human urinary bladder cancer cells through a reactive oxygen species-mediated mitochondrial pathway: the involvement of endoplasmic reticulum stress and the Nrf2 signaling pathway. Int. J. Oncol. 45:1497–1506.
   PubMed Web of Science ®Google Scholar
• Joseph, M. A., Moysich, K. B., Freudenheim, J. L., Shields, P. G., Bowman, E. D., Zhang, Y., Marshall, J. R. and Ambrosone, C. B. (2004). Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1, and prostate cancer risk. Nutr. Cancer 50:206–213.
   PubMed Web of Science ®Google Scholar
• Joshipura, K. J., Ascherio, A., Manson, J. E., Stampfer, M. J., Rimm, E. B., Speizer, F. E., Hennekens, C. H., Spiegelman, D. and Willett, W. C. (1999). Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA 282:1233–1239.
   PubMed Web of Science ®Google Scholar
• Kallifatidis, G., Rausch, V., Baumann, B., Apel, A., Beckermann, B. M., Groth, A., Mattern, J., Li, Z., Kolb, A., Moldenhauer, G., Altevogt, P., Wirth, T., Werner, J., Schemmer, P., Buchler, M. W., Salnikov, A. V. and Herr, I. (2009). Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut 58:949–963.
   PubMed Web of Science ®Google Scholar
• Kanematsu, S., Yoshizawa, K., Uehara, N., Miki, H., Sasaki, T., Kuro, M., Lai, Y. C., Kimura, A., Yuri, T. and Tsubura, A. (2011). Sulforaphane inhibits the growth of KPL-1 human breast cancer cells in vitro and suppresses the growth and metastasis of orthotopically transplanted KPL-1 cells in female athymic mice. Oncol. Rep. 26:603–608.
   PubMed Web of Science ®Google Scholar
• Karin, M. and Dhar, D. (2016). Liver carcinogenesis: from naughty chemicals to soothing fat and the surprising role of NRF2. Carcinogenesis 37:541–546.
   PubMed Web of Science ®Google Scholar
• Kensler, T. W., Chen, J. G., Egner, P. A., Fahey, J. W., Jacobson, L. P., Stephenson, K. K., Ye, L., Coady, J. L., Wang, J. B., Wu, Y., Sun, Y., Zhang, Q. N., Zhang, B. C., Zhu, Y. R., Qian, G. S., Carmella, S. G., Hecht, S. S., Benning, L., Gange, S. J., Groopman, J. D. and Talalay, P. (2005). Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China. Cancer Epidemiol., Biomarkers Prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 14:2605–2613.
   Google Scholar
• Kensler, T. W., Egner, P. A., Agyeman, A. S., Visvanathan, K., Groopman, J. D., Chen, J. G., Chen, T. Y., Fahey, J. W. and Talalay, P. (2013). Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. Top. Curr. Chem. 329:163–177.
   PubMed Web of Science ®Google Scholar
• Kensler, T. W. and Wakabayashi, N. (2010). Nrf2: friend or foe for chemoprevention? Carcinogenesis 31:90–99.
   PubMed Web of Science ®Google Scholar
• Keum, Y. S. (2011). Regulation of the Keap1/Nrf2 system by chemopreventive sulforaphane: implications of posttranslational modifications. Ann. N. Y. Acad. Sci. 1229:184–189.
   PubMed Web of Science ®Google Scholar
• Key, T. (2011). Fruit and vegetables and cancer risk. Br. J. Cancer 104:6–11.
   PubMed Web of Science ®Google Scholar
• Kim, D. H., Sung, B., Kang, Y. J., Hwang, S. Y., Kim, M. J., Yoon, J. H., Im, E. and Kim, N. D. (2015). Sulforaphane inhibits hypoxia-induced HIF-1alpha and VEGF expression and migration of human colon cancer cells. Int. J. Oncol. 47:2226–2232.
   PubMed Web of Science ®Google Scholar
• Kim, J. and Keum, Y. S. (2016). NRF2, a Key Regulator of Antioxidants with Two Faces towards Cancer. Oxid. Med. Cell. Longev. 2016:2746457.
   PubMed Web of Science ®Google Scholar
• Kim, M. R., Zhou, L., Park, B. H. and Kim, J. R. (2011). Induction of G(2)/M arrest and apoptosis by sulforaphane in human osteosarcoma U2-OS cells. Mol. Med. Rep. 4:929–934.
   PubMed Web of Science ®Google Scholar
• Knatko, E. V., Ibbotson, S. H., Zhang, Y., Higgins, M., Fahey, J. W., Talalay, P., Dawe, R. S., Ferguson, J., Huang, J. T., Clarke, R., Zheng, S., Saito, A., Kalra, S., Benedict, A. L., Honda, T., Proby, C. M. and Dinkova-Kostova, A. T. (2015). Nrf2 Activation Protects against Solar-Simulated Ultraviolet Radiation in Mice and Humans. Cancer Prev. Res. (Phila) 8:475–486.
   PubMed Web of Science ®Google Scholar
• Ko, J.-Y., Choi, Y.-J., Jeong, G.-J. and Im, G.-I. (2013). Sulforaphane–PLGA microspheres for the intra-articular treatment of osteoarthritis. Biomaterials 34:5359–5368.
   PubMed Web of Science ®Google Scholar
• Kraft, A. D., Johnson, D. A. and Johnson, J. A. (2004). Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J. Neurosci. 24:1101–1112.
   PubMed Web of Science ®Google Scholar
• Lan, F., Pan, Q., Yu, H. and Yue, X. (2015). Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/beta-catenin signaling in glioblastoma. J. Neurochem. 134:811–818.
   PubMed Web of Science ®Google Scholar
• Lau, A., Wang, X. J., Zhao, F., Villeneuve, N. F., Wu, T., Jiang, T., Sun, Z., White, E. and Zhang, D. D. (2010). A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol. Cell. Biol. 30:3275–3285.
   PubMed Web of Science ®Google Scholar
• Lau, A., Zheng, Y., Tao, S., Wang, H., Whitman, S. A., White, E. and Zhang, D. D. (2013). Arsenic inhibits autophagic flux, activating the Nrf2-Keap1 pathway in a p62-dependent manner. Mol. Cell. Biol. 33:2436–2446.
   PubMed Web of Science ®Google Scholar
• Lee, C. S., Cho, H. J., Jeong, Y. J., Shin, J. M., Park, K. K., Park, Y. Y., Bae, Y. S., Chung, I. K., Kim, M., Kim, C. H., Jin, F., Chang, H. W. and Chang, Y. C. (2015). Isothiocyanates inhibit the invasion and migration of C6 glioma cells by blocking FAK/JNK-mediated MMP-9 expression. Oncol. Rep. 34:2901–2908.
   PubMed Web of Science ®Google Scholar
• Lee, Y. R., Noh, E. M., Han, J. H., Kim, J. M., Hwang, B. M., Kim, B. S., Lee, S. H., Jung, S. H., Youn, H. J., Chung, E. Y. and Kim, J. S. (2013). Sulforaphane controls TPA-induced MMP-9 expression through the NF-kappaB signaling pathway, but not AP-1, in MCF-7 breast cancer cells. BMB Rep. 46:201–206.
   PubMed Web of Science ®Google Scholar
• Lenzi, M., Fimognari, C. and Hrelia, P. (2014). Sulforaphane as a promising molecule for fighting cancer. Cancer Treat. Res. 159:207–223.
   PubMedGoogle Scholar
• Li, Q., Xia, J., Yao, Y., Gong, D. W., Shi, H. and Zhou, Q. (2013). Sulforaphane inhibits mammary adipogenesis by targeting adipose mesenchymal stem cells. Breast Cancer Res. Treat. 141:317–324.
   PubMed Web of Science ®Google Scholar
• Li, Z., Liu, Y., Fang, Z., Yang, L., Zhuang, M., Zhang, Y., Zhao, W. and Sun, P. (2014). Variation of sulforaphane levels in broccoli (Brassica oleracea var. italica) during flower development and the role of gene AOP2. J. Liq. Chromatogr. Rel. Technol. 37:1199–1211.
   Web of Science ®Google Scholar
• Liang, H., Li, C., Yuan, Q. and Vriesekoop, F. (2008). Application of high-speed countercurrent chromatography for the isolation of sulforaphane from broccoli seed meal. J. Agric. Food. Chem. 56:7746–7749.
   PubMed Web of Science ®Google Scholar
• Lin, L. C., Yeh, C. T., Kuo, C. C., Lee, C. M., Yen, G. C., Wang, L. S., Wu, C. H., Yang, W. C. and Wu, A. T. (2012). Sulforaphane potentiates the efficacy of imatinib against chronic leukemia cancer stem cells through enhanced abrogation of Wnt/beta-catenin function. J. Agric. Food Chem. 60:7031–7039.
   PubMed Web of Science ®Google Scholar
• Liu, M., Yao, X. D., Li, W., Geng, J., Yan, Y., Che, J. P., Xu, Y. F. and Zheng, J. H. (2015). Nrf2 sensitizes prostate cancer cells to radiation via decreasing basal ROS levels. Biofactors 41:52–57.
   PubMed Web of Science ®Google Scholar
• Liu, Y., Kern, J. T., Walker, J. R., Johnson, J. A., Schultz, P. G. and Luesch, H. (2007). A genomic screen for activators of the antioxidant response element. Proc. Natl. Acad. Sci. U. S. A. 104:5205–5210.
   PubMed Web of Science ®Google Scholar
• López‐Cervantes, J., Tirado‐Noriega, L. G., Sánchez‐Machado, D. I., Campas‐Baypoli, O. N., Cantú‐Soto, E. U. and Núñez‐Gastélum, J. A. (2013). Biochemical composition of broccoli seeds and sprouts at different stages of seedling development. Int. J. Food Sci. Tech. 48:2267–2275.
   Web of Science ®Google Scholar
• Lozanovski, V. J., Houben, P., Hinz, U., Hackert, T., Herr, I. and Schemmer, P. (2014). Pilot study evaluating broccoli sprouts in advanced pancreatic cancer (POUDER trial) - study protocol for a randomized controlled trial. Trials 15:204.
   PubMed Web of Science ®Google Scholar
• Maheo, K., Morel, F., Langouet, S., Kramer, H., Le Ferrec, E., Ketterer, B. and Guillouzo, A. (1997). Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res. 57:3649–3652.
   PubMed Web of Science ®Google Scholar
• Manchali, S., Murthy, K. N. C. and Patil, B. S. (2012). Crucial facts about health benefits of popular cruciferous vegetables. J. Funct. Foods 4:94–106.
   Web of Science ®Google Scholar
• Matile, P. (1980). The mustard oil bomb-compartmentation of the myrosinase system. Biochem. Physiol. Pflanz. 175:722–731.
   Google Scholar
• Meeran, S. M., Patel, S. N. and Tollefsbol, T. O. (2010). Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS One 5:e11457.
   PubMed Web of Science ®Google Scholar
• Menegon, S., Columbano, A. and Giordano, S. (2016). The Dual Roles of NRF2 in Cancer. Trends Mol. Med. 22:578–593.
   PubMed Web of Science ®Google Scholar
• Mirmiran, P., Noori, N., Zavareh, M. B. and Azizi, F. (2009). Fruit and vegetable consumption and risk factors for cardiovascular disease. Metabolism 58:460–468.
   PubMed Web of Science ®Google Scholar
• Moi, P., Chan, K., Asunis, I., Cao, A. and Kan, Y. W. (1994). Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc. Natl. Acad. Sci. U. S. A. 91:9926–9930.
   PubMed Web of Science ®Google Scholar
• Mondal, A., Biswas, R., Rhee, Y. H., Kim, J. and Ahn, J. C. (2016). Sulforaphene promotes Bax/Bcl2, MAPK-dependent human gastric cancer AGS cells apoptosis and inhibits migration via EGFR, p-ERK1/2 down-regulation. Gen. Physiol. Biophys. 35:25–34.
   PubMed Web of Science ®Google Scholar
• Moon, D. O., Kang, S. H., Kim, K. C., Kim, M. O., Choi, Y. H. and Kim, G. Y. (2010). Sulforaphane decreases viability and telomerase activity in hepatocellular carcinoma Hep3B cells through the reactive oxygen species-dependent pathway. Cancer Lett. 295:260–266.
   PubMed Web of Science ®Google Scholar
• Muller, T. and Hengstermann, A. (2012). Nrf2: friend and foe in preventing cigarette smoking-dependent lung disease. Chem. Res. Toxicol. 25:1805–1824.
   PubMed Web of Science ®Google Scholar
• Myzak, M. C., Karplus, P. A., Chung, F.-L. and Dashwood, R. H. (2004). A novel mechanism of chemoprotection by sulforaphane inhibition of histone deacetylase. Cancer Res. 64:5767–5774.
   PubMed Web of Science ®Google Scholar
• Myzak, M. C., Karplus, P. A., Chung, F. L. and Dashwood, R. H. (2004). A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res. 64:5767–5774.
   PubMed Web of Science ®Google Scholar
• Neuhouser, M. L., Patterson, R. E., Thornquist, M. D., Omenn, G. S., King, I. B. and Goodman, G. E. (2003). Fruits and vegetables are associated with lower lung cancer risk only in the placebo arm of the β-carotene and retinol efficacy trial (CARET). Cancer Epidemiol. Biomarkers Prev. 12:350–358.
   PubMed Web of Science ®Google Scholar
• Nian, H., Delage, B., Ho, E. and Dashwood, R. H. (2009). Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds. Environ. Mol. Mutagen. 50:213–221.
   PubMed Web of Science ®Google Scholar
• Ohta, T., Iijima, K., Miyamoto, M., Nakahara, I., Tanaka, H., Ohtsuji, M., Suzuki, T., Kobayashi, A., Yokota, J., Sakiyama, T., Shibata, T., Yamamoto, M. and Hirohashi, S. (2008). Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res. 68:1303–1309.
   PubMed Web of Science ®Google Scholar
• Pan, H., He, M., Liu, R., Brecha, N. C., Yu, A. C. and Pu, M. (2014). Sulforaphane protects rodent retinas against ischemia-reperfusion injury through the activation of the Nrf2/HO-1 antioxidant pathway. PLoS One 9:e114186.
   PubMed Web of Science ®Google Scholar
• Park, S. Y., Kim, G. Y., Bae, S. J., Yoo, Y. H. and Choi, Y. H. (2007). Induction of apoptosis by isothiocyanate sulforaphane in human cervical carcinoma HeLa and hepatocarcinoma HepG2 cells through activation of caspase-3. Oncol. Rep. 18:181–187.
   PubMed Web of Science ®Google Scholar
• Parnaud, G., Li, P., Cassar, G., Rouimi, P., Tulliez, J., Combaret, L. and Gamet-Payrastre, L. (2004). Mechanism of sulforaphane-induced cell cycle arrest and apoptosis in human colon cancer cells. Nutr. Cancer 48:198–206.
   PubMed Web of Science ®Google Scholar
• Pastorek, M., Simko, V., Takacova, M., Barathova, M., Bartosova, M., Hunakova, L., Sedlakova, O., Hudecova, S., Krizanova, O., Dequiedt, F., Pastorekova, S. and Sedlak, J. (2015). Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy. Int. J. Oncol. 47:51–60.
   PubMed Web of Science ®Google Scholar
• Pawlik, A., Wiczk, A., Kaczynska, A., Antosiewicz, J. and Herman-Antosiewicz, A. (2013). Sulforaphane inhibits growth of phenotypically different breast cancer cells. Eur. J. Nutr. 52:1949–1958.
   PubMed Web of Science ®Google Scholar
• Peng, X., Zhou, Y., Tian, H., Yang, G., Li, C., Geng, Y., Wu, S. and Wu, W. (2015). Sulforaphane inhibits invasion by phosphorylating ERK1/2 to regulate E-cadherin and CD44v6 in human prostate cancer DU145 cells. Oncol. Rep. 34:1565–1572.
   PubMed Web of Science ®Google Scholar
• Piberger, A. L., Keil, C., Platz, S., Rohn, S. and Hartwig, A. (2015). Sulforaphane inhibits damage-induced poly (ADP-ribosyl)ation via direct interaction of its cellular metabolites with PARP-1. Mol. Nutr. Food Res. 59:2231–2242.
   PubMed Web of Science ®Google Scholar
• Piberger, A. L., Koberle, B. and Hartwig, A. (2014). The broccoli-born isothiocyanate sulforaphane impairs nucleotide excision repair: XPA as one potential target. Arch. Toxicol. 88:647–658.
   PubMed Web of Science ®Google Scholar
• Pradhan, S. J., Mishra, R., Sharma, P. and Kundu, G. C. (2010). Quercetin and sulforaphane in combination suppress the progression of melanoma through the down-regulation of matrix metalloproteinase-9. Exp. Ther. Med. 1:915–920.
   PubMed Web of Science ®Google Scholar
• Rajendran, P., Kidane, A. I., Yu, T. W., Dashwood, W. M., Bisson, W. H., Lohr, C. V., Ho, E., Williams, D. E. and Dashwood, R. H. (2013). HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates. Epigenetics 8:612–623.
   PubMed Web of Science ®Google Scholar
• Rausch, V., Liu, L., Kallifatidis, G., Baumann, B., Mattern, J., Gladkich, J., Wirth, T., Schemmer, P., Buchler, M. W., Zoller, M., Salnikov, A. V. and Herr, I. (2010). Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics. Cancer Res. 70:5004–5013.
   PubMed Web of Science ®Google Scholar
• Razis, A., Faizal, A., Iori, R. and Ioannides, C. (2011). The natural chemopreventive phytochemical R‐sulforaphane is a far more potent inducer of the carcinogen‐detoxifying enzyme systems in rat liver and lung than the S‐isomer. Int. J. Cancer 128:2775–2782.
   PubMed Web of Science ®Google Scholar
• Robert, T., Vanoli, F., Chiolo, I., Shubassi, G., Bernstein, K. A., Rothstein, R., Botrugno, O. A., Parazzoli, D., Oldani, A., Minucci, S. and Foiani, M. (2011). HDACs link the DNA damage response, processing of double-strand breaks and autophagy. Nature 471:74–79.
   PubMed Web of Science ®Google Scholar
• Roy, S. K., Srivastava, R. K. and Shankar, S. (2010). Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. J. Mol. Signal. 5:10.
   PubMedGoogle Scholar
• Rushmore, T. H. and Kong, A. N. (2002). Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr. Drug Metab. 3:481–490.
   PubMed Web of Science ®Google Scholar
• Russo, G. L. (2007). Ins and outs of dietary phytochemicals in cancer chemoprevention. Biochem. Pharmacol. 74:533–544.
   PubMed Web of Science ®Google Scholar
• Russo, M., Spagnuolo, C., Tedesco, I. and Russo, G. L. (2010). Phytochemicals in cancer prevention and therapy: truth or dare? Toxins (Basel) 2:517–551.
   PubMed Web of Science ®Google Scholar
• Sasaki, H., Suzuki, A., Shitara, M., Hikosaka, Y., Okuda, K., Moriyama, S., Yano, M. and Fujii, Y. (2013). Genotype analysis of the NRF2 gene mutation in lung cancer. Int. J. Mol. Med. 31:1135–1138.
   PubMed Web of Science ®Google Scholar
• Satoh, H., Moriguchi, T., Takai, J., Ebina, M. and Yamamoto, M. (2013). Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis. Cancer Res. 73:4158–4168.
   PubMed Web of Science ®Google Scholar
• Shan, Y., Sun, C., Zhao, X., Wu, K., Cassidy, A. and Bao, Y. (2006). Effect of sulforaphane on cell growth, G(0)/G(1) phase cell progression and apoptosis in human bladder cancer T24 cells. Int. J. Oncol. 29:883–888.
   PubMed Web of Science ®Google Scholar
• Shan, Y., Wang, X., Wang, W., He, C. and Bao, Y. (2010). p38 MAPK plays a distinct role in sulforaphane-induced up-regulation of ARE-dependent enzymes and down-regulation of COX-2 in human bladder cancer cells. Oncol. Rep. 23:1133–1138.
   PubMed Web of Science ®Google Scholar
• Shen, G., Xu, C., Chen, C., Hebbar, V. and Kong, A. N. (2006). p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1. Cancer Chemother. Pharmacol. 57:317–327.
   PubMed Web of Science ®Google Scholar
• Singh, S. V., Herman-Antosiewicz, A., Singh, A. V., Lew, K. L., Srivastava, S. K., Kamath, R., Brown, K. D., Zhang, L. and Baskaran, R. (2004). Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2-mediated phosphorylation of cell division cycle 25C. J. Biol. Chem. 279:25813–25822.
   PubMed Web of Science ®Google Scholar
• Singletary, K. and MacDonald, C. (2000). Inhibition of benzo[a]pyrene- and 1,6-dinitropyrene-DNA adduct formation in human mammary epithelial cells bydibenzoylmethane and sulforaphane. Cancer Lett. 155:47–54.
   PubMed Web of Science ®Google Scholar
• Skupinska, K., Misiewicz-Krzeminska, I., Stypulkowski, R., Lubelska, K. and Kasprzycka-Guttman, T. (2009). Sulforaphane and its analogues inhibit CYP1A1 and CYP1A2 activity induced by benzo[a]pyrene. J. Biochem. Mol. Toxicol. 23:18–28.
   PubMed Web of Science ®Google Scholar
• Solis, L. M., Behrens, C., Dong, W., Suraokar, M., Ozburn, N. C., Moran, C. A., Corvalan, A. H., Biswal, S., Swisher, S. G., Bekele, B. N., Minna, J. D., Stewart, D. J. and Wistuba, I. I. (2010). Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features. Clin. Cancer Res. 16:3743–3753.
   PubMed Web of Science ®Google Scholar
• Sporn, M. B. (1991). Carcinogenesis and cancer: different perspectives on the same disease. Cancer Res. 51:6215–6218.
   PubMed Web of Science ®Google Scholar
• Sporn, M. B. and Suh, N. (2002). Chemoprevention: an essential approach to controlling cancer. Nature Rev. Cancer 2:537–543.
   PubMed Web of Science ®Google Scholar
• Sun, C. C., Li, S. J., Yang, C. L., Xue, R. L., Xi, Y. Y., Wang, L., Zhao, Q. L. and Li, D. J. (2015). Sulforaphane attenuates muscle inflammation in dystrophin-deficient mdx mice via NF-E2-related factor 2 (Nrf2)-mediated inhibition of NF-kappaB signaling pathway. J. Biol. Chem. 290:17784–17795.
   PubMed Web of Science ®Google Scholar
• Tang, L. and Zhang, Y. (2004). Dietary isothiocyanates inhibit the growth of human bladder carcinoma cells. J. Nutr. 134:2004–2010.
   PubMed Web of Science ®Google Scholar
• Tarozzi, A., Angeloni, C., Malaguti, M., Morroni, F., Hrelia, S. and Hrelia, P. (2013). Sulforaphane as a potential protective phytochemical against neurodegenerative diseases. Oxid. Med. Cell. Longev. 2013.
   Web of Science ®Google Scholar
• Thejass, P. and Kuttan, G. (2007). Modulation of cell-mediated immune response in B16F-10 melanoma-induced metastatic tumor-bearing C57BL/6 mice by sulforaphane. Immunopharmacol. Immunotoxicol. 29:173–186.
   PubMed Web of Science ®Google Scholar
• Thimmulappa, R. K., Mai, K. H., Srisuma, S., Kensler, T. W., Yamamoto, M. and Biswal, S. (2002). Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 62:5196–5203.
   PubMed Web of Science ®Google Scholar
• Tope, A. M. and Rogers, P. F. (2009). Evaluation of protective effects of sulforaphane on DNA damage caused by exposure to low levels of pesticide mixture using comet assay. J. Environ. Sci. Health. B. 44:657–662.
   PubMed Web of Science ®Google Scholar
• Tortorella, S. M., Royce, S. G., Licciardi, P. V. and Karagiannis, T. C. (2015). Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition. Antioxid. Redox Signal 22:1382–1424.
   PubMed Web of Science ®Google Scholar
• Verhoeven, D. T., Goldbohm, R. A., van Poppel, G., Verhagen, H. and van den Brandt, P. A. (1996). Epidemiological studies on brassica vegetables and cancer risk. Cancer Epidemiol. Biomarkers Prev. 5:733–748.
   PubMed Web of Science ®Google Scholar
• Vermeulen, M., Klopping-Ketelaars, I. W., van den Berg, R. and Vaes, W. H. (2008). Bioavailability and kinetics of sulforaphane in humans after consumption of cooked versus raw broccoli. J. Agric. Food. Chem. 56:10505–10509.
   PubMed Web of Science ®Google Scholar
• Vermeulen, M., Klöpping-Ketelaars, I. W., van den Berg, R. and Vaes, W. H. (2008). Bioavailability and kinetics of sulforaphane in humans after consumption of cooked versus raw broccoli. J. Agric. Food. Chem. 56:10505–10509.
   PubMed Web of Science ®Google Scholar
• Voorrips, L., Goldbohm, R., van Poppel, G., Sturmans, F., Hermus, R. and Van Den Brandt, P. (2000). Vegetable and fruit consumption and risks of colon and rectal cancer in a prospective cohort study The Netherlands Cohort Study on Diet and Cancer. Am. J. Epidemiol. 152:1081–1092.
   PubMed Web of Science ®Google Scholar
• Wang, G. C., Farnham, M. and Jeffery, E. H. (2012). Impact of thermal processing on sulforaphane yield from broccoli (Brassica oleracea L. ssp. italica). J. Agric. Food. Chem. 60:6743–6748.
   PubMed Web of Science ®Google Scholar
• Wang, H., Khor, T. O., Yang, Q., Huang, Y., Wu, T. Y., Saw, C. L., Lin, W., Androulakis, I. P. and Kong, A. N. (2012). Pharmacokinetics and pharmacodynamics of phase II drug metabolizing/antioxidant enzymes gene response by anticancer agent sulforaphane in rat lymphocytes. Mol. Pharm. 9:2819–2827.
   PubMed Web of Science ®Google Scholar
• Wang, X. J., Sun, Z., Villeneuve, N. F., Zhang, S., Zhao, F., Li, Y., Chen, W., Yi, X., Zheng, W., Wondrak, G. T., Wong, P. K. and Zhang, D. D. (2008). Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29:1235–1243.
   PubMed Web of Science ®Google Scholar
• Warburg, O. (1956). On respiratory impairment in cancer cells. Science 124:269–270.
   PubMed Web of Science ®Google Scholar
• Wright, W. E. and Shay, J. W. (2005). Telomere biology in aging and cancer. J. Am. Geriatr. Soc. 53:S292–294.
   PubMed Web of Science ®Google Scholar
• Wu, S., Powers, S., Zhu, W. and Hannun, Y. A. (2016). Substantial contribution of extrinsic risk factors to cancer development. Nature 529:43–47.
   PubMed Web of Science ®Google Scholar
• Xiang, M., Namani, A., Wu, S. and Wang, X. (2014). Nrf2: bane or blessing in cancer? J. Cancer Res. Clin. Oncol. 140:1251–1259.
   PubMed Web of Science ®Google Scholar
• Xu, C., Shen, G., Yuan, X., Kim, J. H., Gopalkrishnan, A., Keum, Y. S., Nair, S. and Kong, A. N. (2006). ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells. Carcinogenesis 27:437–445.
   PubMed Web of Science ®Google Scholar
• Xue, M., Qian, Q., Adaikalakoteswari, A., Rabbani, N., Babaei-Jadidi, R. and Thornalley, P. J. (2008). Activation of NF-E2–related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease. Diabetes 57:2809–2817.
   PubMed Web of Science ®Google Scholar
• Yao, H., Wang, H., Zhang, Z., Jiang, B. H., Luo, J. and Shi, X. (2008). Sulforaphane inhibited expression of hypoxia-inducible factor-1alpha in human tongue squamous cancer cells and prostate cancer cells. Int. J. Cancer 123:1255–1261.
   PubMed Web of Science ®Google Scholar
• Yates, M. S., Tran, Q. T., Dolan, P. M., Osburn, W. O., Shin, S., McCulloch, C. C., Silkworth, J. B., Taguchi, K., Yamamoto, M., Williams, C. R., Liby, K. T., Sporn, M. B., Sutter, T. R. and Kensler, T. W. (2009). Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. Carcinogenesis 30:1024–1031.
   PubMed Web of Science ®Google Scholar
• Yoo, S. H., Lim, Y., Kim, S. J., Yoo, K. D., Yoo, H. S., Hong, J. T., Lee, M. Y. and Yun, Y. P. (2013). Sulforaphane inhibits PDGF-induced proliferation of rat aortic vascular smooth muscle cell by up-regulation of p53 leading to G1/S cell cycle arrest. Vascul. Pharmacol. 59:44–51.
   PubMed Web of Science ®Google Scholar
• Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., Wilkinson, M. R., Vadodaria, B., Chen, X., McGee, R. B., Hines-Dowell, S., Nuccio, R., Quinn, E., Shurtleff, S. A., Rusch, M., Patel, A., Becksfort, J. B., Wang, S., Weaver, M. S., Ding, L., Mardis, E. R., Wilson, R. K., Gajjar, A., Ellison, D. W., Pappo, A. S., Pui, C. H., Nichols, K. E. and Downing, J. R. (2015). Germline mutations in predisposition genes in pediatric cancer. N. Engl. J. Med. 373:2336–2346.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., Wang, S., Zhou, S., Yan, X., Wang, Y., Chen, J., Mellen, N., Kong, M., Gu, J. and Tan, Y. (2014). Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway. J. Mol. Cell. Cardiol. 77:42–52.
   PubMed Web of Science ®Google Scholar